U.S. Markets open in 38 mins.

Aeterna Zentaris Inc. (AEZS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.95-0.12 (-5.80%)
At close: 4:00PM EDT
People also watch
KERXCYCCAVEOGALEOPXA
Full screen
Previous Close2.07
Open2.07
Bid1.78 x 300
Ask1.98 x 500
Day's Range1.95 - 2.09
52 Week Range0.78 - 5.59
Volume660,509
Avg. Volume2,737,826
Market Cap28.67M
BetaN/A
PE Ratio (TTM)-0.86
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Associated Press6 days ago

    Aeterna Zentaris reports 2Q loss

    The Montreal-based company said it had a loss of 18 cents per share. Losses, adjusted for non-recurring gains, were 46 cents per share. The drug developer posted revenue of $243,000 in the period. In the ...

  • SmarterAnalyst24 days ago

    AEterna Zentaris Inc. (USA) (AEZS) CEO’s Departure Raises Questions

    AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are tumbling nearly 7% in Monday's trading session, following the news that CEO David Dodd is stepping down and will be succeed by Michael Ward. Most recently, Ward served as Chief Compliance & Legal Officer and Corporate Secretary for Sagent Pharmaceuticals and led its sale to Nichi-Iko Pharmaceutical for $736 million. If David Dodd turned around AEZS, why is he out?

  • Maxim Hikes Price Targets on 2 Biotech Stocks: AEterna Zentaris Inc. (USA) (AEZS), Vertex Pharmaceuticals Incorporated (VRTX)
    SmarterAnalyst29 days ago

    Maxim Hikes Price Targets on 2 Biotech Stocks: AEterna Zentaris Inc. (USA) (AEZS), Vertex Pharmaceuticals Incorporated (VRTX)

    Many investors hope to win big on biotech stocks as shares can skyrocket when there is good news. Maxim analysts explain why there are plenty of promising developments in store for AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), while raising their price targets. Let’s take a closer look.